Alice Frank

Alice is a senior clinical pharmacist with particular interest and expertise in mental health and substance use disorders. She has extensive experience in various clinical and leadership roles within Victorian Public Health Services. She was responsible for establishing the clinical mental health pharmacist ward based service at Northern Health and the expansion of clinical mental health pharmacist services at Austin Health, including to community teams. In 2021, she was also a contributing author to the report commissioned by the Department of Health that informed the addition of tramadol, pregabalin and gabapentin to SafeScript. Recently, she was 1 of the 30 selected participants in VAADA’s AOD Leadership Accelerator Pilot Program.  She is passionate about the significant positive impact that pharmacists have in ensuring optimal, individual-centred, and evidence-based treatments, especially for those individuals experiencing co-occurring mental health and substance use concerns.